Tables for predicting adult height from skeletal age: Revised for use with the greulich-pyle hand standards

Bayley, Nancy; Pinneau, Samuel R.

doi:10.1016/s0022-3476(52)80205-7

Cited by 1,069 publications

(537 citation statements)

References 4 publications

Supporting

Mentioning

495

Contrasting

Unclassified

Order By: Relevance

“…The remaining boys were followed to completion of puberty. We considered their PFHt at Tanner stage 5 as their FHt, since by that time, their BA was 15.5 -16 years, at which point the PFHt is accurate in both boys with a normal growth pattern as well as short boys, either SGA or AGA, with early or delayed puberty (23,26).…”

Section: Resultsmentioning

confidence: 99%

Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)

Lazar¹,

Pollak²,

Kalter‐Leibovici³

et al. 2003

Eur J Endocrinol

View full text Add to dashboard Cite

Objective: Few data are available on the pubertal development of children born small for gestational age (SGA) who fail to show catch-up growth. Design: A longitudinal analysis compared the pubertal course of persistently short children born SGA compared to children with idiopathic short stature who were appropriate for gestational age (AGA). One hundred and twenty-eight short children (height SDS , 21.7), including 76 (31 boys) born SGA and 52 (22 boys) born AGA, were regularly followed from early childhood to completion of puberty. Results: Puberty was attained at normal age (10.5 -14 years in boys, 9.5-13 years in girls) for most children in both the SGA and AGA groups (boys, 80% and 77%; girls, 76% and 78% respectively). The duration of puberty was similar in the SGA and AGA groups. Menarche occurred at normal age range but was significantly earlier in the SGA girls (P , 0.01 by ANOVA). Despite the similar total pubertal growth, the patterns of growth differed significantly: SGA group -accelerated growth and bone maturation rates from onset of puberty with peak height velocity at Tanner stages 2-3, followed by a decelerated growth rate and earlier fusion of the epiphyses; AGA group -steady progression of bone elongation and maturation throughout puberty (pubertal growth, P , 0.05 in both sexes; bone maturation, P , 0.001 in both sexes). Final height in the SGA group was compromised compared with their target height (P , 0.001). Conclusion: Children born SGA have a normal pubertal course with a distinct pubertal growth pattern. This pattern may represent an altered regulation of their growth modalities.

show abstract

Section: Resultsmentioning

confidence: 99%

Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)

Lazar¹,

Pollak²,

Kalter‐Leibovici³

et al. 2003

Eur J Endocrinol

View full text Add to dashboard Cite

show abstract

“…11 The predicted height was calculated using the Bayley-Pinneau method. 17 Thyroid function tests were monitored yearly in all subjects and replacement with levothyroxine was instituted if the thyroid stimulating hormone (TSH) level was elevated above institutional norms. Gonadal function studies (plasma luteinizing hormone (LH) and follicle stimulating hormone (FSH) levels, plasma-estradiol levels in girls and testosterone levels in boys) were performed in all patients starting at age 10 years.…”

Section: Methodsmentioning

confidence: 99%

Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation

Chemaitilly

Boulad

Heller

et al. 2007

Bone Marrow Transplant

View full text Add to dashboard Cite

Impaired linear growth has been shown to occur in individuals treated during childhood with single-dose and fractionated total body irradiation (TBI) before stem cell transplantation. Our objective was to describe the final heights attained and patient/treatment factors correlating with final height in a cohort of childhood cancer survivors treated with hyperfractionated TBI (total dose 1375 or 1500 cGy). Thirty individuals (18 men In conclusion, treatment with hyperfractionated TBI is associated with a reduction in standing height and an even greater reduction in sitting height. Final height after hyperfractionated TBI was similar to that reported after fractionated TBI.

show abstract

“…Body mass index (BMI) was calculated as weight (in kg) divided by the square of height (in m). Bone age was determined in each participating center according to the Greulich± Pyle standards (16). Relative bone age retardation was calculated as bone age minus chronological age divided by chronological age.…”

Section: Patientsmentioning

confidence: 99%

A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency

Schönaü

Westermann²,

Rauch³

et al. 2001

European Journal of Endocrinology

101

View full text Add to dashboard Cite

Objective: To identify parameters which predict individual growth response to recombinant human GH (rhGH) therapy and to combine these parameters in a prediction model. Design: Fifty-eight prepubertal patients with GH deficiency (17 females) participated in this prospective multicenter trial with 1 year of follow-up. Methods: Auxological measurements, parameters of GH status and markers of bone metabolism were measured at baseline and at 1, 3 and 6 months after the start of rhGH treatment. Correlations with height velocity during the first 12 months of treatment HV 12 were calculated. Prediction models were derived by multiple regression analysis. Results: The model which best predicted HV 12 combined the following parameters: pretreatment bone age retardation as a fraction of chronological age, pretreatment serum levels of IGF-I, urinary levels of deoxypyridinoline (a marker of bone resorption) after 1 month of treatment and height velocity after 3 months of treatment. This model explained 89% of the variation in HV 12 with a standard deviation of the residuals of 0.93 cm/year. Defining successful rhGH therapy as a doubling of pretreatment height velocity, the model had a specificity of 90% and a sensitivity of 100% in predicting therapeutic success. Conclusions: This model is an accurate and practicable tool to predict growth response in GH-deficient children. It may help to optimize rhGH therapy by individual dose adjustment and contribute to improved overall outcomes.European Journal of Endocrinology 144 13±20

show abstract

Tables for predicting adult height from skeletal age: Revised for use with the greulich-pyle hand standards

Cited by 1,069 publications

References 4 publications

Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)

Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)

Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation

A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency

Contact Info

Product

Resources

About